In addition, TE-derived peptides can give rise to “neo-antigens,” whose presentation by MHC proteins on the surface of tumor cells can trigger an adaptive anti-tumor immune response (Kong et al., 2019; Laumont et al., 2018), as depicted in Figure 3. Here, HLA-C is linked to neoplasm.